World's Best Scientists 2026 revealed!
Jonathan L. Bramson

Jonathan L. Bramson

D-Index & Metrics

Immunology

D-Index
61
Citations
10755
World Ranking
3272
National Ranking
82

Jonathan L. Bramson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jonathan L. Bramson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 213 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jonathan L. Bramson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan L. Bramson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jonathan L. Bramson is affiliated with McMaster University in Canada and has contributed extensively to medical research, with a focus on oncology, immunology, and molecular biology. Their body of work represents a significant engagement with the study of immune cell function, cancer therapies, and infectious diseases.

The main fields of study associated with Jonathan L. Bramson include Medicine, with subfields such as Oncology, Immunology, Molecular Biology, Infectious Diseases, and Pulmonary and Respiratory Medicine. The research spans several key topics, notably:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • T-cell and B-cell Immunology
  • Viral Infectious Diseases and Gene Expression in Insects
  • Virus-based gene therapy research

Jonathan L. Bramson has published in several frequent venues, prominently including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cytotherapy
  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • OncoImmunology

Their recent papers demonstrate a range of topics within immunotherapy and oncology. Notable publications include:

  • "The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma," 2020, Cell Stem Cell
  • "Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors," 2021, iScience
  • "Metformin-induced reductions in tumor growth involves modulation of the gut microbiome," 2022, Molecular Metabolism
  • "De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors," 2020, Communications Biology
  • "The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy," 2023, Communications Biology

Frequent collaborators in Jonathan L. Bramson's research projects include Joanne A. Hammill, Jessica A. Breznik, Dawn M. E. Bowdish, Ishac Nazy, and Andrew P. Costa. These coauthors have contributed to multiple publications, reflecting sustained research partnerships.

Best Publications

  • Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models

    Raluca Eftimie;Jonathan L. Bramson;David J. D. Earn

  • Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

    J. L. Bramson;M. Hitt;C. L. Addison;W. J. Muller

  • TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

    Anna Zganiacz;Michael Santosuosso;Jun Wang;Tony Yang

  • Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer

    Chris P. Verschoor;Jennie Johnstone;Jamie Millar;Michael G. Dorrington

  • IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.

    M J Greenberger;S L Kunkel;R M Strieter;N W Lukacs

  • A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity

    Fiona Smaill;Mangalakumari Jeyanathan;Marek Smieja;Maria Fe Medina

  • Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

    Theodore Oliphant;Grant E. Nybakken;S. Kyle Austin;Qing Xu

  • Potentiating Cancer Immunotherapy Using an Oncolytic Virus

    Byram W Bridle;Kyle B Stephenson;Jeanette E Boudreau;Sandeep Koshy

  • Maraba virus as a potent oncolytic vaccine vector.

    Jonathan G Pol;Liang Zhang;Byram W Bridle;Kyle B Stephenson

  • Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

    Yonghong Wan;Jonathan Bramson;Ronald Carter;Frank Graham

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • The use of adenoviral vectors for gene therapy and gene transfer in vivo

    Jonathan L Bramson;Frank L Graham;Jack Gauldie

  • Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen presenting cell properties

    Moïra François;Moïra François;Raphaëlle Romieu-Mourez;Sophie Stock-Martineau;Marie Noëlle Boivin

  • Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL

    Lea Luketic;Jordan Delanghe;Paul T. Sobol;Pingchang Yang

  • The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.

    Parvez Vora;Chitra Venugopal;Sabra Khalid Salim;Nazanin Tatari

  • IL-1α/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice

    Fernando M. Botelho;Carla M. T. Bauer;Donna Finch;Jake K. Nikota

  • A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo

    Edward M. Bertram;Wojciech Dawicki;Bradley Sedgmen;Jonathan L. Bramson

  • Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.

    J Bramson;K Dayball;C Evelegh;Y H Wan

  • Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

    J. Bramson;M. Hitt;W. S. Gallichan;K. L. Rosenthal

  • Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

    JL Bramson;M Hitt;J Gauldie;FL Graham

Frequent Co-Authors

Yonghong Wan
Yonghong Wan McMaster University
Mark Loeb
Mark Loeb McMaster University
Brian D. Lichty
Brian D. Lichty McMaster University
Zhou Xing
Zhou Xing McMaster University
Jack Gauldie
Jack Gauldie McMaster University
Dawn M. E. Bowdish
Dawn M. E. Bowdish McMaster University
Frank L. Graham
Frank L. Graham McMaster University
Ali A. Ashkar
Ali A. Ashkar McMaster University
Jeffrey A. Medin
Jeffrey A. Medin Medical College of Wisconsin
Jason Moffat
Jason Moffat University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can broaden career opportunities. Many students consider nursing programs designed for career changers, such as the best online bsn programs for non nurses. These programs provide foundational nursing knowledge, a valuable complement to Immunology expertise.

If you are looking for faster routes into nursing, absn programs with high acceptance rates offer accelerated timelines and more accessible admissions. These programs are ideal for students aiming to quickly enter the nursing workforce.

For entry-level healthcare roles, the fastest and easiest lpn programs can be a practical choice. Licensed Practical Nurses play a vital role in patient care coordination, and this credential can be earned with relative speed.

Those seeking advanced practice can explore options like the easiest nurse practitioner program. Becoming a Nurse Practitioner merges clinical expertise with patient management—skills complementary to an Immunology background and beneficial in specialized healthcare settings.

Best Scientists Citing Jonathan L. Bramson

Trending Scientists

Recently Published Articles